- Benchmark ASINB0GWCX7Q1L
- MarketplaceUS
- Category ID16310091
- Analyzed Products
- Keywordhydrocolloid roll dressing, hydrocolloid wound dressing roll, hydrocolloid tape roll
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-26
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入，已经进入高竞争、低利润的红海区。 新品牌入场很多，近年新释放品牌已达51个、样本新发布98个，但新发布成功率只有16.33%，失败率82.98%，而且多数新产品利润集中在10%以下，说明不是健康增长，而是明显的价格压缩。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很直接：这个市场不适合现在进入，尤其不适合小商家硬冲。 你有50万人民币预算，表面上够覆盖单个ASIN前几个月的进货、运费和推广，但市场已经明显偏向低利润和强竞争，靠正常打法很难跑通。
Early sourcing + logistics + marketing budget (USD)$1,075.72 - $3,080.13Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?5.10%New listing success rate (old brands):0.00%New listing success rate (new brands):17.20%Which new brands have these successful new listings?...Alternatives- 普通透明防水敷贴/岛型敷料：通常比整卷水胶体更容易买到，适合轻微擦伤、贴创口和日常防水保护；不需要裁剪，使用门槛更低。
- 预切水胶体痘痘贴：如果用户主要是为了痘痘护理，预切款更省事，单次使用成本常常更低，也更适合新手直接贴用。
- 泡沫敷料小片：对于有渗液的小伤口，泡沫敷料往往比水胶体卷更容易选规格，且在局部缓冲和吸收方面更直观。
- 凡士林纱布/不粘敷料：用于轻度伤口或敏感皮肤时，价格通常更亲民，且更容易在药店/急救包里找到，替代性强。
- 医用胶布 + 无菌纱布组合：这是更传统、获取更容易的低成本方案，用户可按伤口大小自行搭配，适合临时应急和家用基础护理。
- 硅凝胶贴片/硅胶疤痕贴：如果购买动机偏向术后或皮肤护理，这类产品更适合长时间贴敷，且通常无需像卷材那样自行裁切成形。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不适合进入，结论很明确：已经进入价格战高风险区，而且对大品牌和小商家都不友好。 目前样本里新品盈利率只有16.33%，整体盈利率21.82%，但低价位里大量产品利润只有6.66%~12.0%，已经接近“卖得动但不赚钱”的状态；同时还出现了多款疑似靠激进手段撑销量的竞争对手，说明想靠常规打法突围会很难。
New products with Highest revenueMost investment in new productsYHOVID
Recent Monthly Revenue (USD):-(-)B0H6ZNPCRYBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$17,920.00(2000pcs/month)B0FKGCT3GM (4.4/5 (237 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%
Recent Monthly Revenue (USD):$22,075.00(2500pcs/month)B0FSKLB314 (4.4/5 (233 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Old brand with the most profitable new productsDimora
Recent Monthly Revenue (USD):$70,050.00(3000pcs/month)B0FHVPCVQB (4.5/5 (503 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast investment in new productsAbout life
Recent Monthly Revenue (USD):$555.50(50pcs/month)B0FSQK3CQJ (4.2/5 (39 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatThis listing is deemed profitableLeast profitable new productsEASETEC
Recent Monthly Revenue (USD):-(-)B0GD78XXJX (4.7/5 (34 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0GD78RMN1 (4.7/5 (34 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0GVG3JYDMBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 20英尺超长卷，和常见短卷差异最大
- |
- 适合大面积覆盖和高频使用
- |
- 可裁剪成痘痘贴或伤口敷料，购买场景更广
B0G2M7WDNV (4.6/5 (29 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 半透明隐形外观，更像贴肤护理品
- |
- 2英寸连续卷可自由裁剪，适合精细自制
- |
- 兼顾痘痘贴、水泡贴和小伤口，吸引力强
B0G39M4TG7 (4.7/5 (30 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：已经明显进入红海，而且新品牌成功率并不高，低价竞争非常重。 你当前预算是50万CNY，资金本身不是最大问题，但按市场真实进入成本看，单个新ASIN的常见启动预算大约在1075~3080 USD，中位数1951 USD；真正拉开差距的不是“够不够开品”，而是能不能做出明显差异和持续投放，否则很容易被卷进低利润竞争。
Profitability difficultyModerate Risk for New ProductsAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0FHVPCVQBDimora2025-07-17Yes$23.353000pcs$70050.032.69%$22899.35
B0G6K9NK3BDooWee2026-01-01Yes$13.98600pcs$8388.019.57%$1641.54
B0FLP4DCLGBioemmalab2025-08-08Yes$18.99300pcs$5697.028.33%$1613.97
B0FCDZ5GD6Dkmord2025-06-09Yes$20.58250pcs$5145.030.27%$1557.4
B0FBR1Y8FXPhyyixs2025-07-22Yes$12.12800pcs$9696.014.97%$1451.5
B0FCYDR589Dkmord2025-06-12Yes$12.99300pcs$3897.021.44%$835.52
B0FVZH4C65Pellipatch2025-11-15Yes$19.99125pcs$2498.7528.61%$714.9
B0F5WXFVX8LukToMao2025-04-22Yes$14.52200pcs$2904.024.59%$714.1
B0FLPBFYT4Bioemmalab2025-11-10Yes$12.13300pcs$3639.016.37%$595.71
B0GC5PBP4YLukToMao2025-04-22Yes$17.83100pcs$1783.026.42%$471.07B0GWCX7Q1LKissYee2026-04-29Yes$19.7250pcs$986.031.09%$306.55
B0FR4CF5T9KOCCQUE2025-09-15Yes$18.9350pcs$946.528.2%$266.92
B0FG7K938PCARBOU2025-07-01Yes$17.5550pcs$877.526.61%$233.51B0G2M7WDNVAlpsvox2026-01-31Yes$16.9950pcs$849.522.96%$195.05
B0GGNK5R96Dymmo2026-01-14Yes$9.99150pcs$1498.512.39%$185.67
B0FHMKCCC3GALAXY BEAUTY2025-07-15Yes$15.4850pcs$774.022.2%$171.83
B0FR4PPCK2Muzlineuro2025-09-15Yes$15.950pcs$795.020.96%$166.64
B0FR4KCCHWKOCCQUE2025-09-15Yes$14.1150pcs$705.523.16%$163.4
B0FPF2FSPLRongfeng2025-09-02Yes$14.7450pcs$737.020.87%$153.82
B0GF4GZ9FGSYGO2026-05-31Yes$13.4650pcs$673.017.81%$119.87Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0G6K9NK3BDooWee2026-01-01Yes$13.98600pcs$8388.019.57%$1641.54B0FLP4DCLGBioemmalab2025-08-08Yes$18.99300pcs$5697.028.33%$1613.97B0FVZH4C65Pellipatch2025-11-15Yes$19.99125pcs$2498.7528.61%$714.9B0FLPBFYT4Bioemmalab2025-11-10Yes$12.13300pcs$3639.016.37%$595.71B0GWCX7Q1LKissYee2026-04-29Yes$19.7250pcs$986.031.09%$306.55B0FR4CF5T9KOCCQUE2025-09-15Yes$18.9350pcs$946.528.2%$266.92B0G2M7WDNVAlpsvox2026-01-31Yes$16.9950pcs$849.522.96%$195.05B0GGNK5R96Dymmo2026-01-14Yes$9.99150pcs$1498.512.39%$185.67B0FR4PPCK2Muzlineuro2025-09-15Yes$15.950pcs$795.020.96%$166.64B0FR4KCCHWKOCCQUE2025-09-15Yes$14.1150pcs$705.523.16%$163.4B0FPF2FSPLRongfeng2025-09-02Yes$14.7450pcs$737.020.87%$153.82B0GF4GZ9FGSYGO2026-05-31Yes$13.4650pcs$673.017.81%$119.87
B0FR9GRHRGFRESINIDER2025-09-16Yes$12.9950pcs$649.517.76%$115.36B0G39M4TG7DEBOOB2025-12-15Yes$12.1150pcs$605.517.67%$107.0B0FSQK3CQJAbout life2025-12-13Yes$11.1150pcs$555.514.98%$83.22
B0FQ1J813GVepkuso2025-09-06Yes$9.9950pcs$499.511.12%$55.55#New Product Success Rates
Listing这个市场不值得进入：新品牌新上架成功率只有17.98%，但失败率高达82.02%；更关键的是，老品牌新上架成功率为0%，说明老玩家都打不动，新人也只能靠少数差异化款硬撑，整体是高竞争、高淘汰市场。 市场没有达到“全面饱和”的30个以上新品牌警戒线，但已经明显进入价格压缩和强竞争区：整体可识别产品里，盈利产品只有21.82%，新产品盈利率也只有16.33%，而利润分布里低于10%的产品占了明显一部分，说明不是健康增长，而是靠少数产品抢利润。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
BioemmalabKOCCQUEOtherNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Other#Success Rate by Entry Time
Listing这个市场不值得进入，已经接近/进入过热价格战区。 近一年新品牌入场明显增多，但新发布产品的成功率只有16.33%，失败率高达82.98%；而且最近一批新品里，低利润和亏损产品占比很高，说明竞争正在变得更难，不是更容易。
2025年到2026年，新品牌入场速度很快：2025年新发布产品里，亏损/非盈利新品有73个，2026年继续有20个亏损新品，仅有5个盈利新品；按月份看，2025年9月、2025年12月、2026年3月都出现了明显的失败集中爆发。盈利产品里，真正有代表性的成功案例主要是 Bioemmalab 的 B0FLP4DCLG / B0FLPBFYT4，KOCCQUE 的 B0FR4CF5T9 / B0FR4KCCHW，DooWee 的 B0G6K9NK3B，KissYee 的 B0GWCX7Q1L，利润率大多在12.39%~31.09%，但这些成功并不分散，且大多数新品牌都没跑出来；更关键的是，亏损样本里大量产品利润率落在10%以下，像 NBTREKTIE 的 B0FNM787VG 为 -16.59%，Daiasns 的 B0FNK8SS87 为 -23.93%，ZODENIS 的 B0FRFYL54G 为 -55.62%，这就是典型的价格战区。市场总盈利产品占比只有21.82%，新发布产品盈利占比更低，仅16.33%。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 5 2 7 5 6 0 0 44 2026 0 0 0 3 1 1 0 24 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 3 2 0 0 1 0 0 10 2025/9 1 0 4 2 4 0 0 14 2025/10 0 0 0 0 0 0 0 6 2025/11 0 0 3 1 1 0 0 7 2025/12 1 0 0 2 0 0 0 7 2026/1 0 0 0 2 1 0 0 5 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 7 2026/4 0 0 0 0 0 1 0 2 2026/5 0 0 0 1 0 0 0 4 2026/6 0 0 0 0 0 0 0 5 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesBioemmalabB0FLP4DCLG (4.5/5 (154 Reviews))Hydrocolloid Roll Large Adhesive Bandages Medical Grade Tape Wound Care Dressing, Cut-to-Size Waterproof Patches for Face Acne Pimple, Blister, Burn, Sterile & Fast Healing (2in x 16ft)
This listing is deemed profitablePrice (USD)$18.99Released TypeNew Release (2025-08-08)Brand is a new entry in this marketSize and Weight9.2 x 7.0 x 6.9 cm, 159.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
2英寸宽的连续卷装，可按需裁剪成长条或任意形状Key Buying Motive
可裁剪成任意尺寸，覆盖面更灵活，兼顾痘痘贴和伤口敷料两种需求Target Customers
同时满足痘痘护理、日常小伤口和家庭急救的高频刚需用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$5,697.00300 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight26.56% / 28.33%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight22.49% / 24.26%Peak / Non PeakSales & BSR Performance
BioemmalabB0FLPBFYT4 (4.5/5 (155 Reviews))Hydrocolloid Roll Large Adhesive Bandages Medical Grade Tape Wound Care Dressing, Cut-to-Size Waterproof Patches for Face Acne Pimple, Blister, Burn, Sterile & Fast Healing (2in x 12ft)
This listing is deemed profitablePrice (USD)$12.13Released TypeNew Release (2025-11-10)Brand is a new entry in this marketSize and Weight8.5 x 5.9 x 5.9 cm, 118.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
2英寸×12英尺的大卷装，可按需裁剪，偏向高频自用和家庭急救场景Key Buying Motive
支持按需裁剪成痘痘贴、创口贴或局部敷料，兼顾痘痘护理与日常伤口护理Target Customers
同时覆盖痘痘护理、轻微伤口护理和家庭急救包用户，尤其适合需要大容量、可自裁尺寸的高频使用人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$3,639.00300 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight13.80% / 16.37%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight9.07% / 11.63%Peak / Non PeakSales & BSR Performance
Loading samples... 12%